Zivo Bioscience Inc (ZIVO)
Zivo Bioscience, Inc. is a common stock listing on OTC Markets. The company and its subsidiaries focus on licensing and selling natural bioactive ingredients derived from proprietary algae cultures for use by animal, human, dietary supplement, and medical food manufacturers. Its activities span biotech and agtech applications, supported by an intellectual property portfolio that includes proprietary algal and bacterial strains, biologically active compounds, cultivation methods, production techniques, and patented or patent-pending inventions. Zivo Bioscience’s product and ingredient work includes areas such as poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modulation, functional food ingredients, algal biomass for human food, and biomass associated with skin health and anti-aging. The company was previously known as Health Enhancement Products, Inc. and adopted its current name in October 2014. It is headquartered in Troy, Michigan.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ZIVO
|
$3.98
|
12.0% Upside
|
Fair
|
Not available
|
Not available
|
Weak
|
0.0%
|
63.6x
|
14.738 M
|
14.048 M
|
5.8%
|
37.9%
|
-414.6
|
36.3%
|